DICLOFENAC DIETHYLAMINE + LINSEED OIL + METHYL SALICYLATE + MENTHOL GEL - Pharmacology Ointments may be produced by using the active ingredients in a gel base which is then dispersed and for which the viscosity and distribution of each ingredient has to be controlled to ensure the characteristics of the product are maintained. This topical gel can be used as an additional topical product portfolio to oral and other dosage form pharmaceutical products within a pharmacy portfolio. For the proper portfolio of PCD Pharma Franchise companies, the suitable documentation, packaging, and specifications can be incorporated.
The combination contains Diclofenac Diethylamine which is a non-steroidal anti-inflammatory drug and Linseed Oil, Methyl Salicylate and Menthol which are used in a gel dosage form. These ingredients are likely to have different physicochemical properties hence formulation development involves preparation of a stable and homogeneous system.
The gel base may include appropriate gelling agents, solvents, humectants, preservatives and other pharmaceutical excipients, as appropriate, according to the gel formulation design. Consideration should be given to the compatibility of these excipients with the active ingredients and the physical attributes of the final gel.
Gelling ingredients are compatible with other ingredients during development, and there are some interactions which may influence colour, viscosity, homogeneity or stability. The sequence of addition is also relevant as some ingredients will need to be premixed separately or added gradually into the gel base.
Formulation of the Semisolid base in manufacturing this formulation it is important to develop a standard semisolid base. In the base gelling agent is usually added pre-hydrated or pre dispersed before adding other ingredients. Variables such as agitation rate, temperature and processing time can influence the physical structure of the resultant gel.
Diclofenac Diethylamine is formulated in the finished product, must be evenly dispersed. Depending on solubility and compatibility of individual ingredients, they may be added by dispersing or premixing techniques in compatible solution.
Menthol and Methyl Salicylate Need careful treatment during processing because of their volatile and fragrant nature. It can be reduced in the production process with good working condition and closed manufacturing machinery.
The last aim is to obtain a glatter and homogeneous gel with uniform visual and physical properties across the whole batch.
The base preparation process of DICLOFENAC DIETHYLAMINE + LINSEED OIL + METHYL SALICYLATE + MENTHOL GEL usually consists of controlled preparation of the base, followed by adding the formulation components. This process will depend on the formulation technology and manufacturing equipment.
The raw materials are initially checked against the specifications. The gel base is made under controlled mixing conditions before the active and supporting ingredients can be added in a specific order.
Sensitive process parameters can be mixing speed, mixing time, temperature, deaeration, bulk viscosity etc. Excess agitation can lead to incorporation of air in the gel. If mixing is carried out insufficient time it may lead to nonuniformity.
Hence de-aeration can be achieved as and when necessary to reduce trapped air before filling. In-process evaluation of the appearance, consistency, homogeneity, and such like, can be performed to check the product prior to moving to the packaging phase.
Finished gel has been checked for: appearance, colour, odour, homogeneity, pH (when appropriate), viscosity, fill weight and any other quality control specifications determined in the product development stage.
Lab testing can be used to verify the identity and amount of the relevant active ingredient using validated laboratory techniques. Since the formulation consists of various ingredients, suitable analytical testing is necessary for a proper evaluation.
The gel must stay sufficiently homogeneous over storage, without unacceptable separation, precipitation, phase change or deterioration of physical properties. Microbial quality is also assessed where relevant, as it is necessary to properly control microbial contamination in topical semisolid formulations.
The interaction of the formulation with the container can also be tested or may be induced to obtain information about the container compatibility of the formulation. Changes in the product quality can be recorded.
Packaging is an integral part of the overall development of this topical gel. The formulation can be filled in appropriately sized laminated tubes, aluminium tubes or other compatible pharmaceutical packaging, depending on the pack size and formulation attributes.
The packaging system should provide some degree of protection of the formulation from environmental exposure and prevent avoidable loss of volatile ingredients, in particular Menthol and Methyl Salicylate. Developmental studies can be performed on tube material, closure system, seal retention and dispensing qualities.
The following tests are carried out under specified storage conditions to monitor the physical, viscosity, pH, assay, degradation related substances and micro-biological quality if possible. Packaging condition may be included for checking the suitability of container-closure system during proposed shelf life.
Storage information and batch specific packaging information should be defined according to the finalized product specification and regulations.
The positioning of DICLOFENAC DIETHYLAMINE + LINSEED OIL + METHYL SALICYLATE + MENTHOL GEL within a pharmaceutical company's topical semisolid portfolio can be in the context of other formulation types. Standardised product presentation, standardised packaging and documented specifications for quality support consistency across the range of formulations.
If you are considering a PCD Pharma Franchise business then gels are part of the broadening range of pharma product portfolio. It should contain details of the formulation name, ingredients, strength/concentration (if relevant), packing configuration, storage conditions and manufacturer's information as per the approved artwork.
At each step from formulation development through to final filling, processes are followed and documented quality checks performed. Weights of ingredients combined with mixing, choice of gel base, compatibility of ingredients, viscosity measurements, analytical testing and packaging compatibility all play a part in achieving a uniform topical pharmaceutical product.
In general, this combination gel is a multi-component semisolid formulation with a fragile balance of formulation design and manufacturing controls. A balanced package of raw-material qualification, bulk preparation, homogeneity, quality testing, and packaging can help make each batch of DICLOFENAC DIETHYLAMINE + LINSEED OIL + METHYL SALICYLATE + MENTHOL GEL ready for inclusion in a professional pharmaceutical product portfolio.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech